Markel Corp (MKL)
NYSE:MKL
Top Page
Markel
(NYSE:MKL)
Select Model
Select Model
Rating:74Outperform
Price Target:
$2,312.00
▲(18.60% Upside)
Action:ReiteratedDate:02/27/26
MKL scores well primarily on financial strength (solid profitability, strong and consistent cash generation, and a well-capitalized/low-leverage balance sheet) and a supportive earnings outlook focused on improving underwriting returns. Valuation is also favorable with a P/E near 12. Technicals are the main drag, with mixed trend signals and slightly negative momentum.
Positive Factors
Consistent Cash Generation
Markel's sustained operating cash flow and robust free cash flow provide a durable liquidity cushion that supports underwriting volatility, reserve strength, and disciplined capital allocation. Persistent cash generation funds buybacks, preferred redemption, bolt-on deals and reinvestment without relying on external financing, improving long-term financial flexibility and enabling management to execute multi-year underwriting improvement plans.
Negative Factors
Earnings & Margin Volatility
Markel's earnings demonstrate material cyclicality from underwriting outcomes and investment swings; the 2022 loss and recent margin step‑downs show downside sensitivity. Persistent volatility complicates multi-period forecasting, can impair capital returns during downturns, and forces conservative reserving or capital retention that constrains ROE in volatile years.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Cash Generation
Markel's sustained operating cash flow and robust free cash flow provide a durable liquidity cushion that supports underwriting volatility, reserve strength, and disciplined capital allocation. Persistent cash generation funds buybacks, preferred redemption, bolt-on deals and reinvestment without relying on external financing, improving long-term financial flexibility and enabling management to execute multi-year underwriting improvement plans.
Read all positive factors
Markel (MKL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$24.21B
Dividend YieldN/A
Average Volume (3M)50.67K
Price to Earnings (P/E)13.0
Beta (1Y)0.60
Revenue Growth-6.96%
EPS Growth-26.28%
CountryUS
Employees22,000
SectorFinancial
Sector Strength70
IndustryInsurance - Property & Casualty
Share Statistics
EPS (TTM)33.63
Shares Outstanding12,575,726
10 Day Avg. Volume47,330
30 Day Avg. Volume50,671
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)1.47
Price to Sales (P/S)1.65
P/FCF Ratio10.69
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue1.54
Enterprise Value/Gross Profit2.70
Enterprise Value/Ebitda8.16
Forecast
1Y Price Target
$2,102.33Price Target Upside7.85% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)115.47
Revenue Forecast (FY)$15.38B
Markel Business Overview & Revenue Model
Company Description
Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, Bermuda, the United Kingdom, rest of Europe, Canada, the Asia Pacific, and the Middle East. Its Insurance segment o...
How the Company Makes Money
Markel generates revenue primarily through its insurance operations, which include underwriting premiums collected from policyholders in various sectors, such as liability, workers' compensation, and property insurance. The company also earns inve...
Markel Earnings Call Summary
Earnings Call Date:Feb 04, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Positive
The call conveyed clear progress across the company: improved insurance underwriting results (lower combined ratios and higher insurance adjusted operating income), strong performance in the Financial segment, solid cash generation, and disciplined capital deployment. Management emphasized decisive structural actions (exiting underperforming businesses, leadership changes, simplification) that have started to show “green shoots.” Notable challenges include weaker net investment gains year-over-year, profit pressure in the Industrial segment, discrete large losses in surety and personal umbrella that drove elevated reserves, and a softer competitive pricing environment in U.S. property and portions of London/specialty markets. Management framed the premium reductions from strategic exits as intentional trade-offs to improve long-term combined ratios and returns. Overall the positives—across underwriting improvement, cash flow, capital returns, and Financial segment strength—outweigh the negatives, which are being managed and partially attributable to short-term volatility and deliberate strategic choices.Positive Updates
Improved Insurance Profitability and Combined Ratio
Markel Insurance generated a 92.9% combined ratio in Q4 (vs. 95.9% a year ago, a 3-point improvement) and a 94.6% combined ratio for the full year (1 point better than prior year). Adjusted operating income for the insurance segment was $1.4B for 2025 (up from $1.2B in 2024) and $399M in the quarter (up 31% year-over-year). The segment also produced a 14% return on equity for 2025 (5-year trailing ROE 13%).
Negative Updates
Decline in Net Investment Gains and GAAP Operating Income
Net investment gains were $1.1B in 2025 versus $1.8B in 2024 (a meaningful year-over-year decline). Operating income including investment gains was $3.2B for 2025 versus $3.7B in 2024, reflecting volatility in investment results.
Read all updates
Q4-2025 Updates
Positive
Negative
Improved Insurance Profitability and Combined Ratio
Markel Insurance generated a 92.9% combined ratio in Q4 (vs. 95.9% a year ago, a 3-point improvement) and a 94.6% combined ratio for the full year (1 point better than prior year). Adjusted operating income for the insurance segment was $1.4B for 2025 (up from $1.2B in 2024) and $399M in the quarter (up 31% year-over-year). The segment also produced a 14% return on equity for 2025 (5-year trailing ROE 13%).
Read all positive updates
Company Guidance
Management guided that 2026 will prioritize improving underwriting returns and execution with a target of a sustainable low‑90s combined ratio (about 93%) and higher return on equity (Markel Insurance ROE was 14% in 2025; trailing 5‑yr ROE 13%), driven by portfolio simplification — including exiting Global Reinsurance and a U.S. risk‑managed PL book and converting the Hagerty partnership to a fronting model — actions that will reduce 2026 underwriting GWP by ~$2.0B (Hagerty was 80% ceded / 20% retained in 2025) but are expected to benefit combined ratio, adjusted operating income and ROE; leadership completed 2026 business planning, will double technology investment year‑over‑year and accelerate AI deployments to boost speed and efficiency, will maintain conservative reserving (2025 reserve release = 6 points / $484M) and strong cash generation (operating cash flow $2.8B in 2025), and will continue disciplined capital allocation after a year that included $1.4B fixed‑maturity purchases, $207M capex, $143M net public equity buys, $170M bolt‑on investments, $600M preferred redemption, $430M share repurchases and a $411M increase in cash — all while aiming to convert adjusted operating income (2025 AOI: consolidated $2.3B; Markel Insurance $1.4B) into durable cash returns.Markel Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
82
Very Positive
Cash Flow
80
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.59B | 16.75B | 15.71B | 11.81B | 12.92B |
| Gross Profit | 11.51B | 9.27B | 8.08B | 3.41B | 5.89B |
| EBITDA | 2.94B | 4.18B | 3.16B | 353.94M | 3.65B |
| Net Income | 2.11B | 2.75B | 2.00B | -216.28M | 2.42B |
Balance Sheet | |||||
| Total Assets | 68.91B | 47.35B | 43.44B | 39.28B | 39.38B |
| Cash, Cash Equivalents and Short-Term Investments | 22.40B | 4.19B | 4.33B | 5.22B | 4.88B |
| Total Debt | 5.01B | 5.65B | 4.97B | 4.10B | 5.50B |
| Total Liabilities | -18.60B | 29.88B | 27.92B | 25.54B | 24.18B |
| Stockholders Equity | 18.60B | 16.92B | 14.98B | 13.15B | 14.72B |
Cash Flow | |||||
| Free Cash Flow | 2.55B | 2.34B | 2.53B | 2.45B | 2.13B |
| Operating Cash Flow | 2.76B | 2.59B | 2.79B | 2.71B | 2.27B |
| Investing Cash Flow | -1.31B | -2.40B | -2.70B | -1.67B | -2.94B |
| Financing Cash Flow | -1.09B | -297.88M | -999.72M | -595.31M | 369.77M |
Markel Technical Analysis
Neutral
1949.37
Price Trends
1992.38
Negative
2045.18
Negative
2001.49
Negative
Market Momentum
-14.21
Negative
51.77
Neutral
68.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MKL, the sentiment is Neutral. The current price of 1949.37 is above the 20-day moving average (MA) of 1911.93, below the 50-day MA of 1992.38, and below the 200-day MA of 2001.49, indicating a neutral trend. The MACD of -14.21 indicates Negative momentum. The RSI at 51.77 is Neutral, neither overbought nor oversold. The STOCH value of 68.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MKL.
Markel Risk Analysis
Markel disclosed 20 risk factors in its most recent earnings report. Markel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Markel Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $24.60B | 15.63 | 18.88% | 1.88% | 11.08% | 22.01% | |
77 Outperform | $25.08B | 10.77 | 16.13% | 2.10% | -0.63% | -30.68% | |
74 Outperform | $24.21B | 12.95 | 11.85% | ― | -6.96% | -26.28% | |
74 Outperform | $10.89B | 13.60 | 18.25% | 6.71% | ― | -10.75% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $12.75B | 10.13 | 11.65% | 8.03% | 5.41% | -23.52% | |
59 Neutral | $22.56B | 13.21 | 9.30% | 0.23% | 6.06% | -8.53% |
* Financial Sector Average
MKL
Markel
1,966.19
185.14
10.39%
AFG
American Financial Group
130.57
9.13
7.52%
CINF
Cincinnati Financial
163.35
33.01
25.33%
CNA
CNA Financial
47.25
2.66
5.95%
L
Loews
110.28
24.37
28.36%
WRB
W. R. Berkley Corporation
65.99
-0.59
-0.89%
Markel Corporate Events
Business Operations and StrategyFinancial Disclosures
Markel Highlights Strong 2025 Results in Shareholder Letter
Positive
Feb 27, 2026
On February 26, 2026, Markel Group posted its 2025 Letter to Shareholders, highlighting a strong year in which operating revenues reached $15.5 billion and operating income came in at $3.2 billion, with a combined ratio of 94% and invested assets ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.